Table 4.
Postoperative data of the three groups
| Postoperative data | Study groupsa | P-value | ||
|---|---|---|---|---|
| Group C (n = 39) | Group E (n = 42) | Group Q (n = 39) | ||
| Postoperative chemoradiotherapy | 38 (97.4%) | 36 (85.7%) | 33 (84.6%) | 0.128 |
| QoR-15 score at 3 months | 137.5 (126, 143) | 137.5 (126.5, 143) | 138 (127, 145) | 0.224 |
| First ambulation (min) | 1197.18 ± 184.02 | 1233.33 ± 211.36 | 1121.79 ± 191.69 | 0.707 |
| PONV | 12 (30.8%) | 10 (23.8%) | 6 (15.4%) | 0.274 |
| First oral intake (min) | 1050 (860, 1200) | 1077.5 (970, 1203.75) | 1080 (975, 1215) | 0.311 |
| Flatus and defecation within 24 h | 29 (74.4%) | 30 (71.4%) | 31 (79.5%) | 0.7 |
| Postoperative sufentanil consumption | 88.5 (79.5, 95.2) | 87 (79.5, 97.5) | 94.5 (88.63, 97.88) | 0.093 |
Values are expressed as a number with the percentage in parentheses, as the mean ± standard deviation, or as the median with the inter-quartile range (P25, P75) in parentheses
PONV Postoperative nausea and vomiting, QoR-15 Quality of Recovery—15 Items Scale
aGroup C, group receiving conventional care, with no nerve block; group E, group receiving erector spinae plane block (ESPB); group Q, group receiving posterior quadratus lumborum block (posterior QLB)